Pharmicell Co., Ltd.
- Membership
- BIZ
- Recent Visit
- Nov 19, 2024
- Country / Year Established
-
South Korea
/
- Business type
- Others
- Verified Certificate
-
12
| Product name | Pharmicell Lab the Prestige Essence_45ml | Certification | - |
|---|---|---|---|
| Category | Face Mask | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
By Pharmicell Lab, the Time-Presenting Cosmetic.
Counter Aging Solution
Different from other anti-aging products, it is a beauty solution of new concept to help you nurture young and healthy skin.
About The Product
| By Phrmicell Lab the Prestige Essence_45ml |
Containing 10% of human bone marrow stem cell conditioned media/Certified as wrinkle-improving cosmetic
Functional essence that gives your skin vivacity and vitality to nurture glossy, bright and healthy skin.
- It retrieves your original beauty with it's effective ingredients including adenosine which takes care of your wrinkles by actively Moisturizing your aging skin.
Main Ingredients
- Human bon marrow stem cell conditioned media 10%, ceramide-3, aloe vera leaf extact, hollyhock extract, angraecum callus nurture extract, adenosine, tea tree leaf oil, lavender oil, mozuku extract, dextrine.
How to Use
- Pump out a proper amount of the product and apply it along your face line evenly to be absorbed.
- (Using By Pharmicell Lab The Prestige Cream together with this product is highly recommended for more effective counter aging)
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Hyeonsoo Kim
- Address
- 12F, Chungho-B/D, 3-2, Nonhyeon-dong, Gangnam-gu, Seoul, Korea
- Product Category
- Makeup Brushes
- No. of Total Employees
- 101-500
- Company introduction
-
Pharmicell is devoting itself to the development and commercialization if stem cell therapeutics for the conquest of incurable diseases such as cancer, brain and nervous system disorders, heart diseases that are the most fatal to human beings. Pharmicell is planning to accelerate the development of stem cell therapeutics for acute ischemic stroke(IND-phase 3)and chronic spinal cord injury(IND-phase 2/3)with the experiences relating to the NDA approval of stem cell therapeutics for acute myocardial infarction. In addition, we will continuously launch stem cell therapeutics according to our new drug development pipeline to treat alcoholic cirrhosis, pulmonary fibrosis, and cancer under investigator?s trials and thereby give hope to the patients who are suffering from these incurable diseases. Moreover, we will contribute to the vitalization of the industry related to stem cells through commercialization of stem cell therapeutics, stem cell banking, cell media, CMO(contract Manufacturing Organization), stem cell culturing media, cell processing equipment, cell transport box, manufacturing and quality control software by utilizing our know-how accumulated in the process of commercialization of stem cell therapeutics. This company has secured the intellectual property rights through the registration of patent for stem cell differentiation technology(dendritic cell production technology for anticancer immune treatment and production technology of nerve cells for treatment of brain and nervous system disorders) in foreign countries(7 countries including the US and EU) in order to gain technological competitive edge in the global markets.
- Main Product
